Global mHealth Monitoring And Diagnostic Medical Devices Market 2013-2019: Focus On Medical Devices With In-Built Plug-Ins For Connectivity
M2 - Tue May 13, 10:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7zxll5/mhealth) has announced the addition of the "mHealth Monitoring And Diagnostic Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" report to their offering. The mHealth monitoring and diagnostic devices market has been segmented into seven major product types, namely, glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices and others (fetal monitors, neurological monitors) devices. The market for these devices has been extensively analyzed on the basis of factors such as healthcare and monitoring applications, geographic presence and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The mHealth monitoring and diagnostic devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019. Geographically, the mHealth monitoring and diagnostic devices market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the mHealth monitoring and diagnostic devices market report comprises a qualitative analysis of the overall market considering the factors determining market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. The mHealth monitoring and diagnostic devices market report also provides a highlight of the competitive landscape of the market, wherein the heat map analysis of the leading players in the market in terms of products offered by the companies has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the mHealth monitoring and diagnostic devices market such as AT&T, Inc., Bayer HealthCare AG, BioTelemetry, Inc. (CardioNet, Inc.), Boston Scientific Corporation, DexCom, Inc., Dr?ger AG, F. Hoffmann La-Roche Ltd., Johnson & Johnson, LifeWatch AG, Masimo Corporation, Medtronic, Inc. and Omron Healthcare. The global mHealth monitoring and diagnostic medical devices market is segmented as follows: mHealth Monitoring and Diagnostic Medical Devices Market, by Product Type - Glucose Monitors - Blood Pressure Monitors - Cardiac Monitors - Pulse Oximeters - Sleep Apnea Monitors - Multi-parameter Monitors - Others Companies Mentioned - Bayer HealthCare AG - BioTelemetry, Inc. (CardioNet, Inc.) - Boston Scientific Corporation - DexCom, Inc. - Dr?ger AG - F. Hoffmann-La Roche Ltd. - FitBit, Inc. - Fora Care Inc. - iHealth Labs, Inc. - Johnson & Johnson - LifeWatch AG - Masimo Corporation - Medisana AG - Medtronic, Inc. - Nonin Medical, Inc. - Omron Healthcare, Inc. - Withings, Inc. For more information visit http://www.researchandmarkets.com/research/7zxll5/mhealth
Top Gainers Pre-Market Notes -- Research on bebe stores, BioTelemetry, Axcelis Technologies, and Nanosphere
PR Newswire - Mon May 12, 10:30AM CDT
On Friday, May 9, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average advanced 0.20% to finish the day at 16,583.34, and the S&P 500 closed at 1,878.48, up 0.15%. During the session gains in the Consumer Discretionary, Health Care, and Consumer Staples sectors positively impacted the broader market, while some retraction came in from Utilities, Energy, and Financials sectors. A number of stocks saw large movements, including bebe stores inc. (NASDAQ: BEBE), BioTelemetry Inc. (NASDAQ: BEAT), Axcelis Technologies Inc. (NASDAQ: ACLS) and Nanosphere Inc. (NASDAQ: NSPH). Free technical research on BEBE, BEAT, ACLS and NSPH can be downloaded upon signing up at:
Covance Posts In-line Q1 Earnings; Falls on Trimmed View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 2:30PM CDT
Covance (CVD) reported adjusted earnings per share (EPS) of 90 cents in the first quarter of 2014.
Shares of BEAT Down 25.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu May 08, 9:10AM CDT
SmarTrend identified a Downtrend for CardioNet (NASDAQ:BEAT) on April 10th, 2014 at $9.34. In approximately 4 weeks, CardioNet has returned 25.80% as of today's recent price of $6.93.
Shares of CardioNet Under Pressure, Down 20.6% - May 07, 2014
Comtex SmarTrend(R) - Wed May 07, 9:12AM CDT
CardioNet (NASDAQ:BEAT), a company whose shares are moving quickly, is trading 20.6% lower to $6.88. The S&P is currently trading fractionally higher to 1,869 and the Dow Jones Industrial Average is trading 0.2% higher to 16,441.
How BioTelemetry (BEAT) Stock Stands Out in a Strong Industry - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed May 07, 7:55AM CDT
BioTelemetry might be an intriguing choice for investors as it is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
BioTelemetry, Inc. Reports First Quarter 2014 Financial Results
GlobeNewswire - Tue May 06, 3:24PM CDT
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2014.
Weakness Seen in The Spectranetics Corporation (SPNC) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:44AM CDT
The Spectranetics Corporation has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
PAREXEL Q3 Earnings & Revs Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 2:00PM CDT
For fiscal 2014, PAREXEL International Corporation (PRXL) increased its adjusted EPS guidance to a range of $2.11 to $2.15 from the prior range of $2.01 to $2.11.
BioTelemetry, Inc. to Release First Quarter 2014 Earnings Results on May 6, 2014
GlobeNewswire - Wed Apr 30, 9:52AM CDT
BioTelemetry, Inc. (Nasdaq:BEAT) will release its first quarter 2014 earnings on Tuesday, May 6, 2014 at 4:00 PM Eastern Time.
Omnicare Q1 Earnings Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 1:30PM CDT
Omnicare Inc. (OCR) reported an earnings beat and in-line revenues for the first quarter of 2014, with both increasing on year-over-year bases.
Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
11.0% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Tue Apr 08, 11:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 3rd, 2014 at $8.82. In approximately 2 months, CardioNet has returned 11.00% as of today's recent price of $9.79.
CardioNet Shares Up 17.8% Since SmarTrend's Buy Recommendation (BEAT)
Comtex SmarTrend(R) - Tue Apr 01, 9:59AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 3rd, 2014 at $8.82. In approximately 2 months, CardioNet has returned 17.80% as of today's recent price of $10.39.
BioTelemetry, Inc. Announces the Acquisition of the Cardiac Patient Services Business of Biomedical Systems, Corp.
GlobeNewswire - Thu Mar 20, 7:14AM CDT
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that it has entered into a definitive agreement to acquire the cardiac patient services business of Biomedical Systems, Corp. ("BMS"
CardioNet Up 15.5% Since SmarTrend Uptrend Call (BEAT)
Comtex SmarTrend(R) - Mon Mar 17, 5:33PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 3rd, 2014 at $8.82. In approximately 1 month, CardioNet has returned 15.53% as of today's recent price of $10.19.
CardioNet Earnings In Retrospect: Up 4.9% in the Last 19 Days (BEAT)
Comtex SmarTrend(R) - Mon Mar 17, 7:10AM CDT
Two weeks ago on February 26th, 2014 CardioNet (NASDAQ:BEAT) reported earnings and analysts, on average, expected a loss of $0.02 on sales of $32.3 million. CardioNet actually reported earnings of $0.05 per share on sales of $33.1 million, beating EPS estimates by $0.07 and beating revenue estimates by $0.8 million. Since the company's report, shares of CardioNet have risen from $9.85 to $10.33, representing a gain of 4.9% in the past 19 days.
BioTelemetry (BEAT): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:33AM CDT
BioTelemetry belongs to the Medical Services industry, will be a decent pick, as the company witnessed solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.